Barriers to resection following neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma: A national and local perspective.
Marc W FromerTyler J MouwCharles R ScogginsMichael E EggerPrejesh PhilipsKelly M McMastersRobert C G MartinPublished in: Journal of surgical oncology (2024)
Racial, economic, and educational disparities have a considerable influence on the successful completion of a neoadjuvant approach for resectable PDAC. A comprehensive closed or highly collaborative/communicative multidisciplinary neoadjuvant program is optimal for treatment success and completion.